NCT00380328View on ClinicalTrials.gov

HKI-272 Ketoconazole Drug Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

neratinib

HKI-272

All Listed Sponsors
lead

Puma Biotechnology, Inc.

INDUSTRY

NCT00380328 - HKI-272 Ketoconazole Drug Interaction Study | Biotech Hunter | Biotech Hunter